Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis. [electronic resource]
Producer: 20200716Description: 1792-1804 p. digitalISSN:- 1932-7005
- Cell Differentiation -- drug effects
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Colitis -- pathology
- Dextran Sulfate
- Dinoprostone -- metabolism
- Humans
- Indoleamine-Pyrrole 2,3,-Dioxygenase -- metabolism
- Interferon-gamma -- pharmacology
- Interleukin-1beta -- pharmacology
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- cytology
- T-Lymphocytes, Regulatory -- cytology
- Th1 Cells -- cytology
- Umbilical Cord -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.